CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,672 | -40.1% | 41,471 | +0.9% | 0.00% | – |
| Q2 2023 | $116,276 | -69.0% | 41,087 | -46.1% | 0.00% | – |
| Q1 2023 | $375,000 | +50644.2% | 76,193 | +10.6% | 0.00% | – |
| Q4 2022 | $739 | -100.0% | 68,910 | -80.2% | 0.00% | – |
| Q3 2022 | $3,266,000 | -0.2% | 348,875 | -2.7% | 0.00% | – |
| Q2 2022 | $3,274,000 | -10.0% | 358,647 | +19.9% | 0.00% | – |
| Q1 2022 | $3,636,000 | -10.8% | 299,217 | -10.6% | 0.00% | – |
| Q4 2021 | $4,076,000 | +129.0% | 334,594 | +190.6% | 0.00% | – |
| Q3 2021 | $1,780,000 | +44.8% | 115,124 | +33.6% | 0.00% | – |
| Q2 2021 | $1,229,000 | -34.3% | 86,155 | -0.0% | 0.00% | – |
| Q1 2021 | $1,870,000 | +25.4% | 86,156 | -12.6% | 0.00% | – |
| Q4 2020 | $1,491,000 | +19.4% | 98,521 | -2.7% | 0.00% | – |
| Q3 2020 | $1,249,000 | -31.7% | 101,245 | -5.3% | 0.00% | – |
| Q2 2020 | $1,828,000 | +17.5% | 106,932 | -9.2% | 0.00% | – |
| Q1 2020 | $1,556,000 | -28.1% | 117,782 | -12.3% | 0.00% | – |
| Q4 2019 | $2,164,000 | -18.2% | 134,306 | -7.2% | 0.00% | -100.0% |
| Q3 2019 | $2,645,000 | -9.2% | 144,730 | +5.1% | 0.00% | 0.0% |
| Q2 2019 | $2,914,000 | +9.5% | 137,742 | +1.5% | 0.00% | 0.0% |
| Q1 2019 | $2,661,000 | +50.5% | 135,647 | -0.3% | 0.00% | – |
| Q4 2018 | $1,768,000 | -44.6% | 136,020 | +2.0% | 0.00% | -100.0% |
| Q3 2018 | $3,193,000 | -46.4% | 133,345 | -57.1% | 0.00% | 0.0% |
| Q2 2018 | $5,958,000 | +47.3% | 311,155 | -4.7% | 0.00% | 0.0% |
| Q1 2018 | $4,044,000 | -6.9% | 326,654 | -7.9% | 0.00% | 0.0% |
| Q4 2017 | $4,344,000 | -9.3% | 354,865 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $4,790,000 | -15.0% | 359,875 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $5,635,000 | -11.6% | 366,150 | +5.6% | 0.00% | 0.0% |
| Q1 2017 | $6,376,000 | +86.9% | 346,724 | -5.6% | 0.00% | 0.0% |
| Q4 2016 | $3,412,000 | +10.5% | 367,250 | -0.7% | 0.00% | 0.0% |
| Q3 2016 | $3,089,000 | +51.2% | 369,900 | -12.9% | 0.00% | 0.0% |
| Q2 2016 | $2,043,000 | -36.0% | 424,872 | -17.2% | 0.00% | 0.0% |
| Q1 2016 | $3,194,000 | -45.8% | 513,382 | +46.8% | 0.00% | 0.0% |
| Q4 2015 | $5,894,000 | +6.4% | 349,610 | -9.8% | 0.00% | 0.0% |
| Q3 2015 | $5,538,000 | +130.6% | 387,522 | +96.1% | 0.00% | 0.0% |
| Q2 2015 | $2,402,000 | -13.0% | 197,635 | -28.1% | 0.00% | 0.0% |
| Q1 2015 | $2,762,000 | -12.5% | 274,842 | -13.1% | 0.00% | 0.0% |
| Q4 2014 | $3,155,000 | +6.3% | 316,450 | -10.5% | 0.00% | 0.0% |
| Q3 2014 | $2,967,000 | -50.8% | 353,725 | -0.2% | 0.00% | -50.0% |
| Q2 2014 | $6,035,000 | -11.0% | 354,595 | -2.7% | 0.00% | 0.0% |
| Q1 2014 | $6,780,000 | – | 364,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |